Astellas announced that China NMPA approved XTANDI for the treatment of prostate cancer
The FINANCIAL -- Astellas Pharma Inc. (TSE: 4503, President and CEO: Kenji Yasukawa, Ph.D., "Astellas") today announced that the China National ...
ADVERTISEMENT
Tag: NMPA
Roche’s Tecentriq in combination with Avastin approved in China for people with liver cancer
The FINANCIAL -- Roche (SIX: RO, ROG; OTCQX: RHHBY) today announced that the China National Medical Products Administration (NMPA) has ...
ADVERTISEMENT
Popular Last 24h
-
Priority Reports Record Growth Under Thomas Priore’s Leadership, With EBITDA Soaring 21% in 2024
-
Britons tend not to believe UK tariff rate was down to Starmer’s diplomacy
-
Ampersand wins £22m five-year contract at London Zoo
-
Anurag Bajpayee’s Gradiant : The Water Tech Firm Rides Industrial Demand Toward Global Expansion
-
5 Business Lessons You Can Learn from the Intimate Apparel Industry
-
The London Diplomatic List, Addresses, Contacts & Working Hours
-
What Are the Income Limits for Deducting Traditional IRA Contributions in 2025?
LATEST POSTS
LATESTINTERVIEWS
ADVERTISEMENT
